PHCY 611 EXAM STUDY GUIDE
TBW assumes PK is - Answer Linear
LBW is the weight of - Answer Nonfat components
ADBW may be used to account for - Answer fat tissue
BSA is often used for - Answer chemotherapy
A limitation of BSA is that - Answer it doesn't account for all body types
Height and weight correlate with - Answer cardiac output, blood volume, renal
function
Drug properties of obesity - Answer Increase hepatic clearance: more CYP2E1
-lipophilic = more distribution into fat tissue
-hydrophilic = also a bit more Vd
ADME - Answer Absorption = important for bariatric surgery
Protein binding = relatively unchanged
Distribution = increased fat (lipophilic) and water (hydrophilic) mass
Metabolism = increased phase 1 (CYP2E1)
Excretion = increased in renal clearance/GFR at first then vastly decreases, increased
renal blood flow at first
Low grade inflammation
Hydrophilic drugs - Answer If dosed using TBW, can cause toxicity/overdose
-increase in lean body mass -> increase in hydrophilicity
Increase Vd in obesity - Answer Need higher loading dose to reach Cmax
Increased Cl in obesity - Answer Need higher maintenance dose
Increase GFR - Answer Increased elimination, need to increase dose or frequency
Malabsorptive bariatric surgery - Answer RYGB
Restrictive bariatric surgery - Answer AGB, VSG
Adjustable Gastric Band surgery (AGB) - Answer Restrictive, not as effective, places a
,band on top part of stomach to create small pouch to hold food
Roux-en-Y gastric bypass (RGYB) - Answer Malabsorptive, reattach small intestine up
to smaller pouch of stomach and goes straight to intestine, changing the amount that
gets absorbed
Vertical Sleeve Gastrectomy(VSG) - Answer Restrictive, taking off a part of the
stomach
5HT1A agonist effect - Answer Antidepressant, anxiolytic
5HT3 antagonist effects - Answer anti-nausea, anti-emetic (vomiting)
5HT2a antagonist effect - Answer Improved anxiety, insomnia, sexual dysfunction
5HT2c antagonist effect - Answer Improved anxiety, insomnia, sexual dysfunction,
satiety
5HT2 antagonist effect - Answer anti-diarrhea
Short acting antidepressant (<24 hr) - Answer paroxetine, fluvoxamine, venlafaxine
(other SNRI)
Intermediate acting antidepressant (22-38hr) - Answer sertraline, citalopram,
escitalopram
long acting antidepressant (48-180hr) - Answer fluoxetine
CYP2D6 inhibitor - Answer paroxetine, fluoxetine (sertraline & duloxetine not as
strong)
CYP1A2 inhibitor - Answer fluvoxamine
SSRI - Answer paroxetine, fluoxetine, sertraline, escitalopram, citalopram,
fluvoxamine
SSRI side effects - Answer GI upset, sexual dysfunction, anxiety, headaches, dry
mouth, sedation, risk of QTc prolongation, high bleeding risk
SNRI - Answer venlafaxine, duloxetine, desvenlafaxine
Also good for pain, migraine
SNRI side effects - Answer -SSRI Side effects: stimulant effects (tachycardia, ↑ BP),
nausea, constipation, sedation
-SNRI discontinuation syndrome (flulike symptoms and electric-like shocks)
-HTN
NDRI - Answer Bupropion
, Benefits those with: sexual dysfunction, weight gain, low energy
CI: seizure, bulimia
5HT2 antagonist and reuptake inhibitor - Answer Trazodone
Causes: sedation, orthostasis, priapism (prolonged erection)
5HT2/3, a2 antagonist - Answer Mirtazapine
Causes: sedation, weight gain
Noradrenergic receptors in SNRI - Answer increases heart rate and suppresses pain
Venlafaxine - Answer dose-dependent
low dose <150mg = SSRI effects
high dose >150mg = SNRI effects
Duloxetine - Answer dual action at low dose
many indication for pain
Bupropion - Answer Drug-induced seizure at high dose (>400mg IR)
Contraindicated in patients with bulimia (electrolyte imbalance, leads to seizure)
Neuroplasticity hypothesis - Answer improved neuroplasticity and glutamate
neurotransmission causes faster and improved response and remission
Dextromethorphan+bupropion - Answer Dex=CYP2D6 substrate, blocks NMDA
receptor -> prevents GABA release -> more glutamate -> antidepressant effect
Bup=CYP2D6 inhibitor, inhibits metabolism of dex
Withdrawal syndrome - Answer Flulike symptoms (chills, GI)
Insomnia
Imbalance
Sensory disturbance
Hyperarousal
What does withdrawal depend on? - Answer Half life
-paroxetine has shortest half life, faster clearance ->higher risk
-fluoxetine has longest half life, slow clearance -> less risk, safe to stop abruptly
Serotonin syndrome - Answer With any drug that increases 5-HT (e.g., MAO inhibitors,
TBW assumes PK is - Answer Linear
LBW is the weight of - Answer Nonfat components
ADBW may be used to account for - Answer fat tissue
BSA is often used for - Answer chemotherapy
A limitation of BSA is that - Answer it doesn't account for all body types
Height and weight correlate with - Answer cardiac output, blood volume, renal
function
Drug properties of obesity - Answer Increase hepatic clearance: more CYP2E1
-lipophilic = more distribution into fat tissue
-hydrophilic = also a bit more Vd
ADME - Answer Absorption = important for bariatric surgery
Protein binding = relatively unchanged
Distribution = increased fat (lipophilic) and water (hydrophilic) mass
Metabolism = increased phase 1 (CYP2E1)
Excretion = increased in renal clearance/GFR at first then vastly decreases, increased
renal blood flow at first
Low grade inflammation
Hydrophilic drugs - Answer If dosed using TBW, can cause toxicity/overdose
-increase in lean body mass -> increase in hydrophilicity
Increase Vd in obesity - Answer Need higher loading dose to reach Cmax
Increased Cl in obesity - Answer Need higher maintenance dose
Increase GFR - Answer Increased elimination, need to increase dose or frequency
Malabsorptive bariatric surgery - Answer RYGB
Restrictive bariatric surgery - Answer AGB, VSG
Adjustable Gastric Band surgery (AGB) - Answer Restrictive, not as effective, places a
,band on top part of stomach to create small pouch to hold food
Roux-en-Y gastric bypass (RGYB) - Answer Malabsorptive, reattach small intestine up
to smaller pouch of stomach and goes straight to intestine, changing the amount that
gets absorbed
Vertical Sleeve Gastrectomy(VSG) - Answer Restrictive, taking off a part of the
stomach
5HT1A agonist effect - Answer Antidepressant, anxiolytic
5HT3 antagonist effects - Answer anti-nausea, anti-emetic (vomiting)
5HT2a antagonist effect - Answer Improved anxiety, insomnia, sexual dysfunction
5HT2c antagonist effect - Answer Improved anxiety, insomnia, sexual dysfunction,
satiety
5HT2 antagonist effect - Answer anti-diarrhea
Short acting antidepressant (<24 hr) - Answer paroxetine, fluvoxamine, venlafaxine
(other SNRI)
Intermediate acting antidepressant (22-38hr) - Answer sertraline, citalopram,
escitalopram
long acting antidepressant (48-180hr) - Answer fluoxetine
CYP2D6 inhibitor - Answer paroxetine, fluoxetine (sertraline & duloxetine not as
strong)
CYP1A2 inhibitor - Answer fluvoxamine
SSRI - Answer paroxetine, fluoxetine, sertraline, escitalopram, citalopram,
fluvoxamine
SSRI side effects - Answer GI upset, sexual dysfunction, anxiety, headaches, dry
mouth, sedation, risk of QTc prolongation, high bleeding risk
SNRI - Answer venlafaxine, duloxetine, desvenlafaxine
Also good for pain, migraine
SNRI side effects - Answer -SSRI Side effects: stimulant effects (tachycardia, ↑ BP),
nausea, constipation, sedation
-SNRI discontinuation syndrome (flulike symptoms and electric-like shocks)
-HTN
NDRI - Answer Bupropion
, Benefits those with: sexual dysfunction, weight gain, low energy
CI: seizure, bulimia
5HT2 antagonist and reuptake inhibitor - Answer Trazodone
Causes: sedation, orthostasis, priapism (prolonged erection)
5HT2/3, a2 antagonist - Answer Mirtazapine
Causes: sedation, weight gain
Noradrenergic receptors in SNRI - Answer increases heart rate and suppresses pain
Venlafaxine - Answer dose-dependent
low dose <150mg = SSRI effects
high dose >150mg = SNRI effects
Duloxetine - Answer dual action at low dose
many indication for pain
Bupropion - Answer Drug-induced seizure at high dose (>400mg IR)
Contraindicated in patients with bulimia (electrolyte imbalance, leads to seizure)
Neuroplasticity hypothesis - Answer improved neuroplasticity and glutamate
neurotransmission causes faster and improved response and remission
Dextromethorphan+bupropion - Answer Dex=CYP2D6 substrate, blocks NMDA
receptor -> prevents GABA release -> more glutamate -> antidepressant effect
Bup=CYP2D6 inhibitor, inhibits metabolism of dex
Withdrawal syndrome - Answer Flulike symptoms (chills, GI)
Insomnia
Imbalance
Sensory disturbance
Hyperarousal
What does withdrawal depend on? - Answer Half life
-paroxetine has shortest half life, faster clearance ->higher risk
-fluoxetine has longest half life, slow clearance -> less risk, safe to stop abruptly
Serotonin syndrome - Answer With any drug that increases 5-HT (e.g., MAO inhibitors,